fluorodeoxyglucose f18 has been researched along with Pancreatic Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehghani, L; Kramkimel, N; Larger, E; Lebtahi, R; Mallone, R; Mikail, N; Soyer, P | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Pancreatic Insufficiency
| Article | Year |
|---|---|
Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment.
Topics: Antineoplastic Agents, Immunological; Autoimmune Diseases; Biomarkers; Diffusion Magnetic Resonance Imaging; Exocrine Pancreatic Insufficiency; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lipase; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Neoplasm Proteins; Nivolumab; Pancreatitis; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals | 2018 |